DAF-16
DAF-16 is the sole C. elegans member of the FOXO transcription factor family β the single ancestral worm gene that mammals have expanded to four paralogs (6). It is the canonical longevity transcription factor of invertebrate aging biology: loss of DAF-16 activity fully suppresses the near-doubling of lifespan seen in daf-2 (IIS receptor) loss-of-function animals 1, and overexpression or nuclear activation of DAF-16 is sufficient to extend lifespan in multiple contexts. The central regulatory logic β reduced insulin/IGF signaling β AKT inactivity β nuclear FOXO β longevity gene expression β is conserved from worm to mammals (see foxo3).
Identity
- UniProt: O16850 (DAF16_CAEEL; Swiss-Prot reviewed)
- NCBI Gene: 172981
- WormBase: WBGene00000912
- HGNC: null β worm gene; no human HGNC entry
- GenAge: not independently listed; longevity effects captured via daf-2 (GenAge entry) and the IIS pathway
- Length: 541 amino acids (canonical isoform per UniProt O16850); at least 8 isoforms produced by alternative splicing per current WormBase/UniProt annotations β the founding papers described 3 isoforms: daf-16a1, daf-16a2, and daf-16b (Ogg 1997), plus 2 alternatively spliced forms in the Lin 1997 cDNA analysis (510 aa and 508 aa); the expanded count reflects subsequent WormBase curation. Isoform-specific sequence lengths should be confirmed against current WormBase needs-canonical-id
- Mammalian orthologs: FOXO1, FOXO3, FOXO4, FOXO6 β DAF-16 is the single ancestral FOXO; functionally closest to FOXO3 in the context of longevity regulation 2
Domain organization
DAF-16 shares the canonical FOXO domain architecture:
| Domain | Approximate residues (canonical isoform) | Function |
|---|---|---|
| N-terminal disordered region | 1β174 | Contains AKT phosphorylation sites (see below); intrinsically disordered |
| Forkhead DNA-binding domain (FHD) | 175β268 (UniProt) | Sequence-specific binding to DAF-16 binding elements (DBEs); also binds DAE (DAF-16 associated elements) |
| Nuclear export sequence (NES) | C-terminal to FHD | 14-3-3βmediated cytoplasmic retention when AKT-phosphorylated |
| C-terminal transactivation domain | ~400β541 | Transcriptional activation; isoform variation at C-terminus affects target-gene selectivity |
Key phosphorylation sites
AKT-1 and AKT-2 phosphorylate DAF-16 at three conserved sites analogous to the mammalian AKT sites on FOXO3 (Thr32, Ser253, Ser315):
- Thr273 β confirmed phosphothreonine per UniProt O16850; promotes 14-3-3 binding β cytoplasmic sequestration
- Ser319 β phosphorylated by SGK-1 (serum/glucocorticoid kinase ortholog) and CaMK2 ortholog UNC-43 per UniProt
- Additional AKT-1/AKT-2-dependent sites have been mapped biochemically; full site-by-site epistasis not yet published at atomic resolution needs-replication
JNK-1 (stress-activated kinase) phosphorylates DAF-16 to promote nuclear import under stress conditions β an AKT-opposing phosphorylation 2.
Regulation by the IIS pathway
The IGF-1 signaling (IIS) pathway is the primary upstream regulator of DAF-16 nuclear localization:
DAF-2 (insulin/IGF-1 receptor) β AGE-1 (PI3K catalytic subunit)
β PIP3 β PDK-1 β AKT-1 / AKT-2
β phospho-DAF-16 β 14-3-3 binding β cytoplasmic retention β INACTIVE
Under low IIS (food scarcity, stress, genetic daf-2 or age-1 LoF):
Low PIP3 β AKT-1/AKT-2 inactive β DAF-16 unphosphorylated
β nuclear import β target gene transactivation β longevity program
PPTR-1 (PP2A regulatory subunit B56) dephosphorylates AKT-1 to oppose this pathway, providing a second tier of DAF-16 activation 2. needs-replication β PPTR-1 mechanism is known from a limited number of studies.
DAF-16 nuclear localization was directly visualized using GFP::DAF-16 reporter strains 3; dynamic translocation from cytoplasm to nucleus in response to reduced IIS is one of the clearest in-vivo demonstrations of kinase-controlled transcription factor localization in any organism. (Note: the full nuclear translocation dynamics upon daf-2 perturbation were characterized in subsequent work β Lin et al. 2001, Nat Genet 28:139 β not by Lin 1997, which is a cloning paper.) needs-canonical-id
Key genetic interactions
daf-2 (IIS receptor) β founding paper
daf-2 loss-of-function (LoF) mutants live ~twice as long as wild-type N2 worms 1. This lifespan extension is completely suppressed by simultaneous daf-16 LoF β demonstrating that DAF-16 is the essential effector of daf-2 longevity 1. This result, published in 1993, launched the modern era of longevity genetics.
| Dimension | Status | Notes |
|---|---|---|
| Pathway conserved in humans? | yes | IIS β AKT β FOXO axis highly conserved; identical phosphorylation sites |
| Phenotype conserved in humans? | partial | FOXO3A variants associate with human longevity (see foxo3); no direct equivalent of daf-2 LoF longevity in humans |
| Replicated in humans? | no | Cannot LoF the insulin/IGF receptor for longevity in humans; observational GWAS data only |
needs-human-replication β Causal longevity evidence is entirely invertebrate (and some mammalian model-organism); direct evidence in humans is observational only.
sir-2.1 (sirtuin) β DAF-16-dependent longevity
Overexpression of sir-2.1 (the C. elegans ortholog of mammalian SIRT1) extends lifespan in a DAF-16-dependent manner: sir-2.1 overexpression no longer extends lifespan when daf-16 is knocked down 4. This established DAF-16 as a critical downstream effector of sirtuin-mediated longevity in worms β though later work in flies and mammals complicated the conserved-sirtuin-longevity narrative (see sirt1).
aak-2 (AMPK) β parallel pathway, not upstream
aak-2 (AAK-2; C. elegans AMPK Ξ±-subunit) LoF shortens lifespan ~12%; daf-16 LoF shortens lifespan; aak-2;daf-16 double mutants are ~15% shorter-lived than either single mutant 5. This additive shortening in the double mutant demonstrates that AAK-2 and DAF-16 act in parallel, not a linear AAK-2 β DAF-16 hierarchy 5. The AMPK pathway therefore extends lifespan via a DAF-16-independent route in worms β a key constraint when extrapolating mammalian AMPK-longevity mechanisms.
hsf-1 (heat-shock factor) β partial cooperation
HSF-1 (heat-shock factor 1) and DAF-16 cooperate to promote longevity downstream of daf-2 LoF 6. Simultaneous knockdown of both hsf-1 and daf-16 further shortens daf-2 lifespan beyond either alone, suggesting partially independent transcriptional programs converge on the longevity phenotype 6. no-fulltext-access β Hsu 2003 (Science) is closed-access; claims cannot be independently verified from local PDF.
Downstream transcriptional program
A microarray study by Murphy et al. 2003 identified DAF-16 target genes systematically 7. The DAF-16 regulon includes:
- Stress-resistance genes: sod-3 (MnSOD ortholog), hsp-12.6 (small heat-shock protein), mtl-1 (metallothionein)
- Antimicrobial genes: lys-7 and multiple lysozyme-family members β DAF-16 links longevity to innate immunity
- Metabolic genes: lipid-binding proteins, fatty acid metabolic enzymes
- Negative regulators: daf-16 also activates inhibitors of its own pathway (feedback), including pptr-1 (PP2A regulatory subunit)
The DAF-16 regulon is divided into genes that require nuclear DAF-16 for activation (Class I β repressed by IIS) and genes that require nuclear DAF-16 for repression (Class II β activated by IIS) 7. Both classes contribute to longevity; the Class II set includes several pro-aging genes.
Aging context and model-organism translation
DAF-16 is the entry point for understanding transcriptional control of aging. It demonstrates that:
- A single transcription factor can substantially reprogram lifespan β DAF-16 nuclear activity increases maximum lifespan nearly twofold in daf-2 LoF animals.
- The IIS-FOXO axis is ancient and conserved β the same logic (reduced insulin signaling β nuclear FOXO β longevity) operates in flies (dFOXO), mice (Igf1r+/- β FOXO activation; see igf1r), and potentially humans (FOXO3A GWAS β see foxo3).
- Longevity is transcriptionally programmed, not just passively accumulated damage β DAF-16 target genes actively defend against stress and infection, reframing aging as a regulated process 2.
The major limitation is quantitative: daf-2 LoF in a poikilothermic invertebrate with a 3-week lifespan does not translate directly to magnitude of effect in mammals. Mammalian IIS pathway reduction in mice yields modest lifespan extensions ranging from ~15% to 40% across different perturbations (see igf1r), not twofold 2. needs-replication β the specific Igf1r+/- female mouse extension figure (~26% in Holzenberger 2003) is not stated explicitly in Kenyon 2010; the review gives a range across multiple mouse models.
Nomenclature note
The gene name daf-16 derives from βabnormal DAuer Formationβ β DAF-16 was originally identified as a regulator of dauer larva entry (the C. elegans hibernation-like state induced by starvation/crowding). The connection between dauer regulation and longevity reflects the conserved logic: IIS low β daf-16 nuclear β dauer/longevity programs. Downstream dauer and longevity targets partially overlap but are not identical. See caenorhabditis-elegans for dauer biology context.
Gaps and limitations
- needs-human-replication β All causal longevity data from C. elegans (and partially from mice/flies); no human LoF equivalent.
- needs-canonical-id β Isoform-specific sequence lengths and phosphosite assignments vary by isoform; canonical isoform boundaries should be confirmed against WormBase.
- no-fulltext-access β Kenyon 1993 (
10.1038/366461a0) and Hsu 2003 (10.1126/science.1083701) are closed-access; quantitative claims from those papers cannot be verified against local PDFs. - needs-replication β Exact phosphosite mapping for all 8 isoforms; PPTR-1 dephosphorylation mechanism; relative contributions of DAF-16 isoforms to different phenotypic outputs.
- no-mechanism β How nuclear DAF-16 distinguishes Class I from Class II target genes at the chromatin level (co-factor specificity not fully characterized).
Pathway membership
- insulin-igf1 β primary regulatory context; DAF-16 is the key transcriptional output
- ampk β parallel longevity pathway (aak-2 acts in parallel, not upstream)
- deregulated-nutrient-sensing β hallmark overlap: DAF-16 is the effector linking reduced nutrient sensing to longevity
Related pages
- foxo3 β primary mammalian ortholog; human aging-associated GWAS hits
- daf-2 β upstream insulin/IGF receptor; daf-2 LoF is the founding longevity mutation
- age-1 β PI3K ortholog; AGE-1 is the catalytic PI3K downstream of DAF-2
- sir-2.1 β sirtuin whose longevity effect requires DAF-16
- aak-2 β AMPK ortholog; parallel longevity effector
- caenorhabditis-elegans β model organism context; IIS pathway in worm aging
- insulin-igf1 β the pathway DAF-16 gates
- ampk β the parallel pathway
- akt β AKT1/2 human ortholog; phosphorylates FOXO family members in mammals
Footnotes
Footnotes
-
doi:10.1038/366461a0 Β· Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R Β· in-vivo (C. elegans) Β· daf-2(e1370) LoF ~2Γ lifespan; completely suppressed by daf-16 LoF Β· model: C. elegans N2 and mutant strains Β· not_oa no-fulltext-access β© β©2 β©3
-
doi:10.1038/nature08980 Β· Kenyon CJ Β· review (Nature) Β· comprehensive review of IIS-FOXO axis across species; DAF-16 target genes; mammalian extrapolation; magnitude attenuation Β· local PDF available β© β©2 β©3 β©4 β©5
-
doi:10.1038/40194 Β· Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, Tissenbaum HA, Ruvkun G Β· in-vivo (C. elegans) Β· parallel cloning of daf-16 as forkhead TF; identified three alternatively spliced isoforms (daf-16a1, daf-16a2, daf-16b) with distinct forkhead DNA-binding domains; epistasis with daf-2 and age-1; daf-16a::GFP expressed broadly in ectoderm, muscle, intestine, neurons (not pharynx); DAF-16a 65% identical to FKHR and 62% to AFX in forkhead domain Β· model: C. elegans Β· local PDF available β©
-
doi:10.1038/35065638 Β· Tissenbaum HA, Guarente L Β· in-vivo (C. elegans) Β· sir-2.1 OE extends lifespan in DAF-16-dependent manner; daf-16 RNAi abolishes sir-2.1 longevity Β· n per strain = 80β451 (per-strain values in paper) Β· model: C. elegans Β· local PDF available β©
-
doi:10.1101/gad.1255404 Β· Apfeld J, OβConnor G, McDonagh T, DiStefano PS, Curtis R Β· in-vivo (C. elegans) Β· aak-2 LoF shortens lifespan ~12%; aak-2;daf-16 double mutant ~15% shorter than either single β parallel relationship; aak-2 OE extends lifespan ~13% Β· model: C. elegans Β· local PDF available β© β©2
-
doi:10.1126/science.1083701 Β· Hsu AL, Murphy CT, Kenyon C Β· in-vivo (C. elegans) Β· HSF-1 and DAF-16 cooperate downstream of daf-2; partial independence of HSF-1 and DAF-16 longevity programs Β· model: C. elegans Β· not_oa no-fulltext-access β© β©2
-
doi:10.1038/nature01789 Β· Murphy CT, McCarroll SA, Bargmann CI, Fraser A, Kamath RS, Ahringer J, Li H, Kenyon C Β· in-vivo / microarray (C. elegans) Β· systematic identification of DAF-16 target genes; Class I (activated) and Class II (repressed) regulon; sod-3, mtl-1, hsp-12.6, lys-7 as representative Class I targets Β· model: C. elegans Β· local PDF available β© β©2